The children's Hospital of Philadelphia has contributed to the science of the Children's Cancer Study Group in the last 20 years with regard to patient entry on study, scientific leadership in committees and strategy groups, and the initiation and performance of pilot studies. Specific contributions have been the following: 1) Development of ferritin as a biologic marker of neuroblastoma activity and of a histopathologic classification of neuroblastoma following on the earlier work of Evans and D'Angio in the staging of that disease; 2) Development of a multidisciplinary nero- oncology program consisting of neurosurgery, radiology, radiation therapy, neurology and pediatric oncology, which has developed successful clinical trials for brain tumors when none were available in the Group. These have and will be incorporated into randomized Group trials; 3) Initiation of a method of performing edpidemiologic studies utilizing the random-digit dialing technique and assuming responsibility for Group studies of retinoblastoma and brain tumors through NCI funded grants; 4 Providing leadership ad expertise in developing studies of late effects of cncer therapy; and 5) Performing studies for leukemia, Hodgkin's disease, lymphomas, rhabdomyosarcoma, Wilms' tumor, and brain tumors serving as early pilots for the Group. The investigators participating in this endeavor will continue to provide data of high quality for patients entered on CCG studies annually and more than 1,000 are being followed on study; it is expectd that this number will increase in the future since brain tumor, hodgkin's disease and second-line leukemia sxtudies are now available. Approximately 70 new brain tumor patients and 15 each with Hodgkin's disease and relapsed ALL are seen annually here; at least 50 will be entered on studies not previously available. There are 20 investigators in this institution holding 96 positions on study committees, strategy groups, or scientific committees, 19 of them being in positions of leadership. We will continue to enroll all eligible patients and to coform to group requirements with regard to study participation, in addition to providing leadership in the specific areas noted above.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA011796-23
Application #
3556007
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1976-12-01
Project End
1993-11-30
Budget Start
1991-12-01
Budget End
1992-11-30
Support Year
23
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Kelly, Kimberly A; Bardeesy, Nabeel; Anbazhagan, Rajesh et al. (2008) Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med 5:e85
Faca, Vitor M; Song, Kenneth S; Wang, Hong et al. (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5:e123
Kimmelman, Alec C; Hezel, Aram F; Aguirre, Andrew J et al. (2008) Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A 105:19372-7
Neudorf, Steven; Sanders, Jean; Kobrinsky, Nathan et al. (2004) Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103:3655-61
Seitzman, Robin L; Glover, Dorie A; Meadows, Anna T et al. (2004) Self-concept in adult survivors of childhood acute lymphoblastic leukemia: a cooperative Children's Cancer Group and National Institutes of Health study. Pediatr Blood Cancer 42:230-40
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Casillas, Jacqueline N; Woods, William G; Hunger, Stephen P et al. (2003) Prognostic implications of t(10;11) translocations in childhood acute myelogenous leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 25:594-600
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600

Showing the most recent 10 out of 21 publications